Open Urology and Nephrology Journal最新文献

筛选
英文 中文
Editorial Pediatric Nephrology: an Update 儿科肾脏病学:最新进展
Open Urology and Nephrology Journal Pub Date : 2015-01-01 DOI: 10.2174/1874303x01508010090
A. Barakat
{"title":"Editorial Pediatric Nephrology: an Update","authors":"A. Barakat","doi":"10.2174/1874303x01508010090","DOIUrl":"https://doi.org/10.2174/1874303x01508010090","url":null,"abstract":"Pediatric nephrology is rapidly evolving. Over the last few decades we have witnessed a rapid change in nosology, etiology, pathogenesis and treatment of renal disease. We have seen advances in renal and urinary tract imaging as well as more precise use of novel urinary biomarkers to define the type and degree of renal injury, both acute and chronic. We now have better understanding of factors contributing to normal and abnormal renal development, particularly the progenitors of renal development and regeneration, delivery of progenitor cell therapeutics, and the role of epigenetics [1]. Multi center pan-national and international clinical studies have helped to put together clinical guidelines to diagnose and manage renal disease. In this issue, we will discuss few, but important recent clinical developments in pediatric nephrology.","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68066877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 156
Progress in Pediatric Kidney Transplantation 儿童肾移植研究进展
Open Urology and Nephrology Journal Pub Date : 2014-12-31 DOI: 10.2174/1874303X014070100115
Jodi M. Smith, V. Dharnidharka
{"title":"Progress in Pediatric Kidney Transplantation","authors":"Jodi M. Smith, V. Dharnidharka","doi":"10.2174/1874303X014070100115","DOIUrl":"https://doi.org/10.2174/1874303X014070100115","url":null,"abstract":"&## (# )# \"# %# # ’( ## #% #\" #) #( &# &% ’( ## #% #\" #) #( &# &% ! \"## $## %## &## # ’( ## #% #\" #) #( &# &% ’( ## #% #\" #) #( &# &% # %# \"# )# (# )*&# +) &&*&, !\"## ! $#% !\"## & $#% !\"## \" # # ! ! \"# $%& ! ’(!! ))* + ! \"# - - &## (# )# \"# %# # ’( ## #% #\" #) #( &# &% ’( ## #% #\" #) #( &# &% ’( ## #% #\" #) #( &# )!* &%!* \",\" ,\" Significant progress has been made in pediatric kidney","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 1","pages":"115-122"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68065473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation. 延长缬更昔洛韦预防儿童肾移植巨细胞病毒感染的疗效观察。
Open Urology and Nephrology Journal Pub Date : 2014-12-31 eCollection Date: 2014-01-01 DOI: 10.2174/1874303X01407010152
Faris Hashim, Jon A Gregg, Vikas R Dharnidharka
{"title":"Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation.","authors":"Faris Hashim,&nbsp;Jon A Gregg,&nbsp;Vikas R Dharnidharka","doi":"10.2174/1874303X01407010152","DOIUrl":"https://doi.org/10.2174/1874303X01407010152","url":null,"abstract":"<p><p>Cytomegalovirus (CMV) is one of the most frequent opportunistic infection in renal transplant (RTx) recipients. Valganciclovir (VGC) has been showed to be safe and highly effective in prophylaxis of CMV infection in RTx recipients. Recently, an increase in delayed onset CMV disease has been noted with some arguing that longer prophylaxis may decrease the late-onset disease. We retrospectively tested the hypothesis that extended term prophylaxis (ETP) of VGC for 12 months is more effective than short term prophylaxis (STP) of 6 months in preventing CMV infection and disease in pediatric RTx performed at the University of Florida from July 2003 to December 2010. In this period, all recipients underwent prospective CMV PCR (Polymerase Chain Reaction) monitoring and were maintained on similar immunosuppression. Eighty six patients received RTx during that period. All eligible subjects had to have at least 12 months of graft survival and 18 months of follow up, leaving 73 eligible subjects in final study group. CMV infection or disease occurred in 6/29 (20%) in the STP group vs 6/44 (14%) in the ETP group with no statistical significant difference (P= 0.42). Donor positive/recipients negative CMV serology status (D+/R-) were associated with a higher risk of CMV infection in both univariate and multivariate analysis (P=0.01). Anemia and Leucopenia directly associated with VGC were similar in both groups (P=0.58 and P=0.2 respectively). Biopsy-proven acute rejection was also non-significant in both groups (P=0.39). Although ETP for CMV from 6 months to 12 months is safe and has minimal adverse effect, it did not reduce CMV infection or disease. Further controlled studies in pediatrics age group are considered to compare longer versus shorter periods of prophylaxis and their impact on prevention of CMV infection, resistance, cost, and toxicity.</p>","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 Suppl 2 M7","pages":"152-157"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33047064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Intravenous Immunoglobulin in BK Virus Nephropathy 静脉注射免疫球蛋白治疗BK病毒肾病
Open Urology and Nephrology Journal Pub Date : 2014-12-31 DOI: 10.2174/1874303X014070100129
E. Anyaegbu, S. Hmiel
{"title":"Intravenous Immunoglobulin in BK Virus Nephropathy","authors":"E. Anyaegbu, S. Hmiel","doi":"10.2174/1874303X014070100129","DOIUrl":"https://doi.org/10.2174/1874303X014070100129","url":null,"abstract":"The incidence of post transplant viral infections has increased with the use of more potent immunosuppressive regimens. Consequently, BK virus nephropathy (BKVN) has arisen as a significant cause of graft dysfunction and loss. Reduction of immunosuppression is the first line management of post-transplant viral infections. Other therapies such as intravenous immunoglobulin (IVIg), cidofovir, leflunomide and fluoroquinolones have been tried with varying degrees of success. We report our experience with IVIg in three pediatric renal transplant recipients who presented with allograft dysfunction. First, we describe two cases of biopsy proven BKVN, one diagnosed with undetectable viral titers in plasma, demonstrating that BKVN can occur even at low viral loads. We also present a pediatric renal transplant recipient with persistent BK viremia and allograft dysfunction who responded to therapy with recovery of renal function and clearance of viremia. Therefore we conclude that IVIg is efficacious in the treatment of persistent BK viremia and BKVN. The appropriate dose, frequency and duration of therapy require further study.","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 1","pages":"129-132"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68065544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Adherence in Adolescent and Young Adult Kidney Transplant Recipients 青少年和青年肾移植受者的依从性
Open Urology and Nephrology Journal Pub Date : 2014-12-31 DOI: 10.2174/1874303X014070100133
J. Bethany, L. H. P. Ahna
{"title":"Adherence in Adolescent and Young Adult Kidney Transplant Recipients","authors":"J. Bethany, L. H. P. Ahna","doi":"10.2174/1874303X014070100133","DOIUrl":"https://doi.org/10.2174/1874303X014070100133","url":null,"abstract":"Poor adherence to immunosuppressive medications may be the most important barrier to long term graft survival. An understanding of medication adherence and its determinants is critical to addressing this important problem. In this paper, we will review the different ways in which adherence may be compromised, summarize the evidence that young people constitute a particularly high risk group, and consider the consequences and impact of poor adherence. We will also review the determinants of adherence, including characteristics of the patient and family, the treatment regimen, the healthcare team and its organization, and the healthcare system. We will highlight the most common barriers to adherence identified by young people, and consider different methods of measuring adherence, along with the advantages and limitations of each. Finally, we will consider possible intervention strategies to improve adherence in young people.","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 1","pages":"133-143"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68065594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Advances in Pediatric Renal Transplantation 儿童肾移植研究进展
Open Urology and Nephrology Journal Pub Date : 2014-12-31 DOI: 10.2174/1874303X014070100113
R. Vikas
{"title":"Advances in Pediatric Renal Transplantation","authors":"R. Vikas","doi":"10.2174/1874303X014070100113","DOIUrl":"https://doi.org/10.2174/1874303X014070100113","url":null,"abstract":"The science of kidney transplantation in children has advanced remarkably in the last 40 years [1, 2]. As kidney transplants in adult recipients were becoming more common with improving shortand long-term outcomes, results in children were lagging behind. This lag was attributed to multiple factors: greater surgical and technical problems in small children, different metabolism for needed drugs, lack of actionable scientific data, and studies with inadequate sample sizes to make definitive research conclusions, among others.","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 1","pages":"113-114"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68065459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of Asymptomatic Persistent Epstein-Barr Viral Load in Pediatric Renal Transplant Recipients: North American Pediatric Renal Trials and Collaborative Studies Report 儿童肾移植受者无症状持续性Epstein-Barr病毒载量的意义:北美儿童肾脏试验和合作研究报告
Open Urology and Nephrology Journal Pub Date : 2014-12-31 DOI: 10.2174/1874303X014070100123
A. Moudgil, K. Martz, Therese Moore, W. Harmon, V. Dharnidharka
{"title":"Significance of Asymptomatic Persistent Epstein-Barr Viral Load in Pediatric Renal Transplant Recipients: North American Pediatric Renal Trials and Collaborative Studies Report","authors":"A. Moudgil, K. Martz, Therese Moore, W. Harmon, V. Dharnidharka","doi":"10.2174/1874303X014070100123","DOIUrl":"https://doi.org/10.2174/1874303X014070100123","url":null,"abstract":"Background: Many pediatric transplant (TX) centers routinely monitor Epstein-Barr (EB) viral load (VL) by real time quantitative PCR and intervene to prevent post-transplant lymphoproliferative disorder (PTLD). Some children develop asymptomatic persistent VL (PVL). Outcome of different interventions in preventing PTLD and other undesired effects on acute rejection (AR), graft failure (GF) and function amongst children with asymptomatic PVL is not known. Methods: NAPRTCS centers invited to enter data on children with asymptomatic PVL (≥ 6 months) into the EB VL registry. Comparison group included children into the NAPRTCS TX arm during the same period without PVL or VL monitoring. EB VL were arbitrarily divided into low (1-10), medium (>10-100) and high (>100times detection limit for the center) ratio. Results: Of 645 children (18 centers), 85 (13.2%) developed onset of PVL at a mean of 6.4 ± 6.3 months post-TX. PVL children were more likely to be younger (< 5 years) at TX and less likely to be African-American and majority (75.3%) was mismatched for EBV (donor EBV IgG positive and recipient negative). Thymoglobulin induction was used in 29.4% children with PVL versus 37% in controls (p=ns). PTLD developed in 7/85 (8.2%) children with PVL versus 5/560 (0.9%) controls (p < 0.0001). EB VL ratios were not different in those with and without PTLD. EB PVL as time varying covariate did not affect patient survival, GF and AR (HR, 0.85, 0.53 and 0.99). The change in GFR overtime in children with PVL was comparable to controls. Conclusion: Children with PVL (actual load not predictive) are at increased risk for PTLD, but not for AR, death, GF or loss of graft function.","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 1","pages":"123-128"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68065535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Sexuality and Reproductive Health Counseling in Adolescent Renal Transplant Recipients 青少年肾移植受者的性与生殖健康咨询
Open Urology and Nephrology Journal Pub Date : 2014-12-31 DOI: 10.2174/1874303X014070100144
I. Ashoor, Ryan H. Pasternak
{"title":"Sexuality and Reproductive Health Counseling in Adolescent Renal Transplant Recipients","authors":"I. Ashoor, Ryan H. Pasternak","doi":"10.2174/1874303X014070100144","DOIUrl":"https://doi.org/10.2174/1874303X014070100144","url":null,"abstract":"Normal adolescence marks a period of significant physical, cognitive and psychosocial change. It is characterized by transition from concrete to abstract thought processes and concern for risk taking behaviors. Adolescents and young adults with chronic conditions are at a particular disadvantage and tend to be more vulnerable to risky behavior than their healthy peers. While there currently exists no information on the burden of sexually transmitted infections (STIs) in adolescent renal transplant recipients, they present a particularly worrisome population as they are likely to engage in risk taking behavior when they feel \"normal\" following transplantation to compensate for poor quality of life endured on dialysis. This is further compounded by adolescents' false perception that they are unlikely to acquire such infections, and the likely improvement in libido and sexual functioning after transplantation. The potential for acquiring a sexually transmitted infection is concerning given their immunocompromised status, and complex treatment regimens which might have unfavorable interactions with STI treatments. Also, unintentional pregnancy is likely to have a significant impact on their overall medical condition and social functioning thereby impacting their long term allograft outcomes. As the pediatric nephrologist assumes a primary care provider role for these patients following their renal transplant, it becomes increasingly important to be familiar with basic reproductive health counseling techniques and available contraceptive methods on the market. Until consensus guidelines and specific recommendations for reproductive health counseling are developed for adolescent renal transplant recipients, this review provides a brief summary of available knowledge in those areas.","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 1","pages":"144-151"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68065621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Editorial Advances in Pediatric Renal Transplantation 儿科肾移植的编辑进展
Open Urology and Nephrology Journal Pub Date : 2014-12-16 DOI: 10.2174/1874303X01407010113
V. Dharnidharka
{"title":"Editorial Advances in Pediatric Renal Transplantation","authors":"V. Dharnidharka","doi":"10.2174/1874303X01407010113","DOIUrl":"https://doi.org/10.2174/1874303X01407010113","url":null,"abstract":"","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 1","pages":"113-114"},"PeriodicalIF":0.0,"publicationDate":"2014-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68065568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of End Stage Renal Disease-Bangladesh Perspective 终末期肾病的管理——孟加拉国观点
Open Urology and Nephrology Journal Pub Date : 2014-10-31 DOI: 10.2174/1874303X01407010108
H. Rashid
{"title":"Management of End Stage Renal Disease-Bangladesh Perspective","authors":"H. Rashid","doi":"10.2174/1874303X01407010108","DOIUrl":"https://doi.org/10.2174/1874303X01407010108","url":null,"abstract":"End stage renal disease (ESRD) is an important cause of morbidity and mortality throughout the world. The treatment of renal replacement therapy (RRT) for patients with ESRD is expensive. There is a direct relationship between per capita income and treatment of ESRD. Eighty five per cent of the world's population lives in low income or middle- income countries, where the mortality is highest in patients with chronic kidney disease. The future perspective is not satisfactory for Bangladesh where treatment of ESRD is out of reach for majority of people. Effort should made for prevention and treatment of CKD at an initial stage of disease.","PeriodicalId":38952,"journal":{"name":"Open Urology and Nephrology Journal","volume":"7 1","pages":"108-112"},"PeriodicalIF":0.0,"publicationDate":"2014-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68065558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信